Subramanian Sanjay
Related Filers (2)
Ownership (21)
4
Monday, 3/27/2023
Inozyme Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 4/20/2022
Inozyme Pharma, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 3/22/2022
Inozyme Pharma, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 3/22/2022
Inozyme Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/5/2022
Ocugen, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 12/17/2021
Ocugen, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 11/18/2021
Ocugen, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 10/27/2021
Ocugen, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 10/15/2021
Ocugen, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/18/2021
Ocugen, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 7/16/2021
Ocugen, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/17/2021
Ocugen, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/14/2021
Ocugen, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 5/3/2021
Ocugen, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 2/1/2021
Ocugen, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 1/4/2021
Ocugen, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/7/2020
Ocugen, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 1/3/2020
Ocugen, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/26/2019
Ocugen, Inc.: Statement of changes in beneficial ownership of securities
3
Friday, 10/4/2019
Ocugen, Inc.: Initial statement of beneficial ownership of securities
4
Friday, 10/4/2019
Ocugen, Inc.: Statement of changes in beneficial ownership of securities